RaNA Therapeutics Inks $20.7M

Cambridge, Mass.-based RaNA Therapeutics Inc. has raised $20.7 million in a round of financing co-led by Atlas Venture, SR One and Monsanto, with participation of Partners Innovation Fund. The money will be used for continued development of RaNA’s technology platform to “enable selective activation of target genes and expression of therapeutic factors by targeting a type of regulatory RNA called long non-coding RNA,” the company says.

North AmericaUSBriefs